South Korea · Delayed Price · Currency is KRW Bio Port Korea Statistics
Total Valuation
Bio Port Korea has a market cap or net worth of KRW 27.20 billion. The enterprise value is 19.85 billion.
| Market Cap | 27.20B |
| Enterprise Value | 19.85B |
Important Dates
The next estimated earnings date is Tuesday, April 7, 2026.
| Earnings Date | Apr 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Port Korea has 4.61 million shares outstanding. The number of shares has increased by 16.68% in one year.
| Current Share Class | 4.61M |
| Shares Outstanding | 4.61M |
| Shares Change (YoY) | +16.68% |
| Shares Change (QoQ) | +4.41% |
| Owned by Insiders (%) | 48.37% |
| Owned by Institutions (%) | 0.46% |
| Float | 1.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | 10.94 |
| P/OCF Ratio | 5.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.19, with an EV/FCF ratio of 7.99.
| EV / Earnings | -14.15 |
| EV / Sales | 0.28 |
| EV / EBITDA | 6.19 |
| EV / EBIT | 23.92 |
| EV / FCF | 7.99 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.58 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 3.68 |
| Debt / FCF | 4.75 |
| Interest Coverage | 2.68 |
Financial Efficiency
Return on equity (ROE) is -4.06% and return on invested capital (ROIC) is 2.64%.
| Return on Equity (ROE) | -4.06% |
| Return on Assets (ROA) | 0.99% |
| Return on Invested Capital (ROIC) | 2.64% |
| Return on Capital Employed (ROCE) | 1.91% |
| Weighted Average Cost of Capital (WACC) | 2.84% |
| Revenue Per Employee | 662.43M |
| Profits Per Employee | -13.12M |
| Employee Count | 107 |
| Asset Turnover | 1.35 |
| Inventory Turnover | 9.17 |
Taxes
| Income Tax | -445.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.50% in the last 52 weeks. The beta is -0.19, so Bio Port Korea's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -60.50% |
| 50-Day Moving Average | 6,639.80 |
| 200-Day Moving Average | 10,631.75 |
| Relative Strength Index (RSI) | 40.06 |
| Average Volume (20 Days) | 17,664 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Port Korea had revenue of KRW 70.88 billion and -1.40 billion in losses. Loss per share was -336.14.
| Revenue | 70.88B |
| Gross Profit | 17.32B |
| Operating Income | 830.05M |
| Pretax Income | -1.85B |
| Net Income | -1.40B |
| EBITDA | 3.21B |
| EBIT | 830.05M |
| Loss Per Share | -336.14 |
Balance Sheet
The company has 19.16 billion in cash and 11.81 billion in debt, with a net cash position of 7.35 billion or 1,594.01 per share.
| Cash & Cash Equivalents | 19.16B |
| Total Debt | 11.81B |
| Net Cash | 7.35B |
| Net Cash Per Share | 1,594.01 |
| Equity (Book Value) | 40.47B |
| Book Value Per Share | 8,776.06 |
| Working Capital | 21.88B |
Cash Flow
In the last 12 months, operating cash flow was 4.74 billion and capital expenditures -2.25 billion, giving a free cash flow of 2.49 billion.
| Operating Cash Flow | 4.74B |
| Capital Expenditures | -2.25B |
| Depreciation & Amortization | 2.38B |
| Net Borrowing | -3.72B |
| Free Cash Flow | 2.49B |
| FCF Per Share | 539.22 |
Margins
Gross margin is 24.44%, with operating and profit margins of 1.17% and -1.98%.
| Gross Margin | 24.44% |
| Operating Margin | 1.17% |
| Pretax Margin | -2.61% |
| Profit Margin | -1.98% |
| EBITDA Margin | 4.53% |
| EBIT Margin | 1.17% |
| FCF Margin | 3.51% |
Dividends & Yields
Bio Port Korea does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.68% |
| Shareholder Yield | -16.68% |
| Earnings Yield | -5.16% |
| FCF Yield | 9.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 16, 2025. It was a reverse split with a ratio of 0.1486215.
| Last Split Date | May 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1486215 |
Scores
Bio Port Korea has an Altman Z-Score of 3.7 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.7 |
| Piotroski F-Score | 5 |